These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 18509252

  • 21. Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.
    La Mura V, Pasarín M, Meireles CZ, Miquel R, Rodríguez-Vilarrupla A, Hide D, Gracia-Sancho J, García-Pagán JC, Bosch J, Abraldes JG.
    Hepatology; 2013 Mar; 57(3):1172-81. PubMed ID: 23184571
    [Abstract] [Full Text] [Related]

  • 22. Temporal relationships between levels of circulating NO derivatives, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats.
    Paya D, Maupoil V, Schott C, Rochette L, Stoclet JC.
    Cardiovasc Res; 1995 Dec; 30(6):952-9. PubMed ID: 8746211
    [Abstract] [Full Text] [Related]

  • 23. Gender differences in contractile and relaxing responses of aortic rings from lipopolysaccharide-treated rats.
    Okawa T, Vedernokov YP, Saade GR, Garfield RE.
    Gynecol Endocrinol; 2002 Jun; 16(3):225-33. PubMed ID: 12192895
    [Abstract] [Full Text] [Related]

  • 24. Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings.
    Hamel C, Millette E, Lamontagne D.
    Life Sci; 2005 Jul 22; 77(10):1069-81. PubMed ID: 15978263
    [Abstract] [Full Text] [Related]

  • 25. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice.
    Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A.
    FASEB J; 2003 Apr 22; 17(6):773-5. PubMed ID: 12586741
    [Abstract] [Full Text] [Related]

  • 26. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
    Alvarez De Sotomayor M, Herrera MD, Marhuenda E, Andriantsitohaina R.
    Br J Pharmacol; 2000 Nov 22; 131(6):1179-87. PubMed ID: 11082126
    [Abstract] [Full Text] [Related]

  • 27. Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2.
    Shen KP, Liou SF, Hsieh SL, Chen IJ, Wu BN.
    J Pharm Pharmacol; 2007 Jun 22; 59(6):879-89. PubMed ID: 17637181
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts.
    Tatsumi T, Akashi K, Keira N, Matoba S, Mano A, Shiraishi J, Yamanaka S, Kobara M, Hibino N, Hosokawa S, Asayama J, Fushiki S, Fliss H, Nakagawa M, Matsubara H.
    J Mol Cell Cardiol; 2004 Sep 22; 37(3):775-84. PubMed ID: 15350850
    [Abstract] [Full Text] [Related]

  • 32. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
    Heller J, Sogni P, Tazi KA, Chagneau C, Poirel O, Moreau R, Lebrec D.
    Hepatology; 1999 Sep 22; 30(3):698-704. PubMed ID: 10462376
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of Src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteries.
    Kox M, Wijetunge S, Pickkers P, Hughes AD.
    Vascul Pharmacol; 2007 Mar 22; 46(3):195-200. PubMed ID: 17113356
    [Abstract] [Full Text] [Related]

  • 34. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock.
    Cuzzocrea S, Mazzon E, Di Paola R, Esposito E, Macarthur H, Matuschak GM, Salvemini D.
    J Pharmacol Exp Ther; 2006 Oct 22; 319(1):73-81. PubMed ID: 16815867
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway.
    Takakura K, Mizogami M, Fukuda S.
    Can J Anaesth; 2006 Feb 22; 53(2):162-7. PubMed ID: 16434757
    [Abstract] [Full Text] [Related]

  • 38. Role of nitric oxide produced by constitutive and inducible nitric oxide synthases in the mouse gastric fundus.
    Arab HA, Hassanpour H, Bozorgi A.
    Clin Exp Pharmacol Physiol; 2008 Sep 22; 35(9):1038-42. PubMed ID: 18505451
    [Abstract] [Full Text] [Related]

  • 39. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
    Nagareddy PR, McNeill JH, MacLeod KM.
    Eur J Pharmacol; 2009 Jun 02; 611(1-3):53-9. PubMed ID: 19344709
    [Abstract] [Full Text] [Related]

  • 40. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction].
    Han YL, Cheng C, Tan HM, Wu WK, Wu YL, Sun HL, Sun J, Chen JL.
    Zhongguo Zhong Yao Za Zhi; 2007 Nov 02; 32(22):2404-8, 2426. PubMed ID: 18257270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.